MDM4 and glioblastoma: The analysis indicated that most cancer types, including cholangiocarcinoma, glioblastoma, and liver hepatocellular carcinoma (LIHC), demonstrated a significant overexpression of MDMX in malignant tissues compared to adjacent normal tissues (Fig. 1A).